Optimization of Renin-Angiotensin-Aldosterone Inhibitor Therapies for Evidence-Based Indications: a Call to Action From the Cardio-Kidney Community

Optimization of Renin-Angiotensin-Aldosterone Inhibitor Therapies for Evidence-Based Indications: a Call to Action From the Cardio-Kidney Community

Saved in:
Bibliographic Details
Main Authors: Roberto Pecoits-Filho, MD, PhD, Michelle M.Y. Wong, MD, Monica Moorthy, MSc, Debasish Banerjee, MD, Suman Behera, MD, FRCPC, Viviane Calice-Silva, MD, PhD, Mogamat-Yazied Chothia, PhD, Gates B. Colbert, MD, Martha Gulati, MD, MS, Charles A. Herzog, MD, Fadi Jouhra, MD, Edgar V. Lerma, MD, Charu Malik, PhD, Kershaw V. Patel, MD, Amina Rakisheva, MD, Giuseppe M.C. Rosano, MD, PhD, Priyanka Satish, MD, Henry H.L. Wu, MBChB, Angela Yee-Moon Wang, MD, PhD
Format: Article
Language:English
Published: Elsevier 2025-07-01
Series:Kidney International Reports
Subjects:
Renin angiotensin aldosterone inhibitors
chronic kidney disease
heart failure
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024925001792
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items